Using the glioma endothelial cell line U87 it was found that succinylated TAGLN2 recruits and represses the function of thymosin beta 4 X-linked, an inhibitor of actin polymerisation, to initiate cytoskeletal remodelling and glioma migration [91]. The gene discussed is TAGLN2; the disease is central nervous system cancer.